Clinical Trial Update: Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating triglyceride changes in type 2 diabetes patients after conversion from rosiglitazone to pioglitazone has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED